{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T05:50:30Z","timestamp":1670046630136},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T00:00:00Z","timestamp":1612310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T00:00:00Z","timestamp":1612310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hum Genome Var"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We report the first case of classic lipoid congenital adrenal hyperplasia and combined pituitary hormone deficiency. We identified pathogenic variants in the <jats:italic>STAR<\/jats:italic> gene: a novel variant of c.126_127delCCinsG, namely, p.Thr44Profs*2 and an already reported variant of c.634C&gt;T, namely, p.Gln212*. The association with combined pituitary hormone deficiency might be just a coincidence.<\/jats:p>","DOI":"10.1038\/s41439-021-00138-w","type":"journal-article","created":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T06:03:05Z","timestamp":1612332185000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Novel STAR gene variant in a patient with classic lipoid congenital adrenal hyperplasia and combined pituitary hormone deficiency"],"prefix":"10.1038","volume":"8","author":[{"given":"Moritake","family":"Higa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Zaha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Takushi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nami","family":"Morishima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toyofumi","family":"Majikina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Touma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michio","family":"Shimabukuro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Masuzaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misa","family":"Honda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomonobu","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,3]]},"reference":[{"key":"138_CR1","doi-asserted-by":"crossref","unstructured":"Bose, H. S., Sugawara, T., Strauss, J. F. III, Miller, W. L., Consortium ICLAH: International Congenital Lipoid Adrenal Hyperplasia Consortium. The pathophysiology and genetics of congenital lipoid adrenal hyperplasia. N. Engl. J. Med. 335, 1870\u20131878 (1996).","DOI":"10.1056\/NEJM199612193352503"},{"key":"138_CR2","doi-asserted-by":"publisher","first-page":"4781","DOI":"10.1210\/jc.2006-1565","volume":"91","author":"BY Baker","year":"2006","unstructured":"Baker, B. Y. et al. Nonclassic congenital lipoid adrenal hyperplasia: a new disorder of the steroidogenic acute regulatory protein with very late presentation and normal male genitalia. J. Clin. Endocrinol. Metab. 91, 4781\u20134785 (2006).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"138_CR3","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1210\/jc.2018-01752","volume":"104","author":"N Hatabu","year":"2019","unstructured":"Hatabu, N. et al. Pubertal development and pregnancy outcomes in 46,XX patients with nonclassic lipoid congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 104, 1866\u20131870 (2019).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"138_CR4","doi-asserted-by":"publisher","first-page":"dgaa557","DOI":"10.1210\/clinem\/dgaa557","volume":"105","author":"T Ishii","year":"2020","unstructured":"Ishii, T. et al. Clinical features of 57 patients with lipoid congenital adrenal hyperplasia: criteria for nonclassic form revisited. J. Clin. Endocrinol. Metab. 105, dgaa557 (2020).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"138_CR5","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1210\/er.2016-1101","volume":"37","author":"Q Fang","year":"2016","unstructured":"Fang, Q. et al. Genetics of combined pituitary hormone deficiency: roadmap into the genome era. Endocr. Rev. 37, 636\u2013675 (2016).","journal-title":"Endocr. Rev."},{"key":"138_CR6","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1210\/js.2019-00086","volume":"3","author":"T Ishii","year":"2019","unstructured":"Ishii, T. et al. Pubertal and adult testicular functions in nonclassic lipoid congenital adrenal hyperplasia: a case series and review. J. Endocr. Soc. 3, 1367\u20131374 (2019).","journal-title":"J. Endocr. Soc."},{"key":"138_CR7","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1093\/hmg\/6.4.571","volume":"6","author":"J Nakae","year":"1997","unstructured":"Nakae, J. et al. Analysis of the steroidogenic acute regulatory protein (StAR) gene in Japanese patients with congenital lipoid adrenal hyperplasia. Hum. Mol. Genet. 6, 571\u2013576 (1997).","journal-title":"Hum. Mol. Genet."},{"key":"138_CR8","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41439-020-00118-6","volume":"7","author":"J Hamada","year":"2020","unstructured":"Hamada, J. et al. A novel SOX10 variant in a Japanese girl with Waardenburg syndrome type 4C and Kallmann syndrome. Hum. Genome Var. 7, 30 (2020).","journal-title":"Hum. Genome Var."}],"container-title":["Human Genome Variation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41439-021-00138-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41439-021-00138-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41439-021-00138-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T10:05:42Z","timestamp":1669975542000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41439-021-00138-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,3]]},"references-count":8,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["138"],"URL":"https:\/\/doi.org\/10.1038\/s41439-021-00138-w","relation":{},"ISSN":["2054-345X"],"issn-type":[{"value":"2054-345X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,3]]},"assertion":[{"value":"22 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Tomonobu Hasegawa has the following financial relationships to disclose: research funding from Novo Nordisk Pharma Ltd. and JCR Pharmaceuticals Co., Ltd.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"6"}}